We are live on ! Find out more
DE

DV Equities Portfolio holdings

AUM $698M
This Fund
S&P 500
This Quarter Est. Return
+1.76%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$558M
AUM Growth
–
Cap. Flow
+$555M
Cap. Flow %
99.63%
Top 10 Hldgs %
62.7%
Holding
742
New
742
Increased
–
Reduced
–
Closed
–
Avg Time Held Equity + Options
0 quarters
Top 10 Avg Time Held Equity + Options
0 quarters
Top 20 Avg Time Held Equity + Options
0 quarters
Avg Time Held Equity only
0 quarters
Top 10 Avg Time Held Equity only
0 quarters
Top 20 Avg Time Held Equity only
0 quarters

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.53%
2 Technology 9.71%
3 Healthcare 7.71%
4 Financials 7.17%
5 Energy 5.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
CSCO icon
76
Cisco
CSCO
$467B
$426K 0.08%
+5,530
New +$410K
2025 Q4
0 quarters
RACE icon
77
Ferrari
RACE
$68.4B
$422K 0.08%
+1,141
New +$457K
2025 Q4
0 quarters
WFC icon
78
Wells Fargo
WFC
$253B
$409K 0.07%
+4,393
New +$381K
2025 Q4
0 quarters
CRM icon
79
Salesforce
CRM
$189B
$405K 0.07%
+1,529
New +$380K
2025 Q4
0 quarters
BIDU icon
80
Baidu
BIDU
$29B
$393K 0.07%
+3,007
New +$373K
2025 Q4
0 quarters
IBM icon
81
IBM
IBM
$214B
$390K 0.07%
+1,317
New +$394K
2025 Q4
0 quarters
KO icon
82
Coca-Cola
KO
$379B
$378K 0.07%
+5,407
New +$377K
2025 Q4
0 quarters
CDTX
83
PUT
DELISTED
Cidara Therapeutics
CDTX
$376K 0.07%
+1,700
New +$275K
2025 Q4
0 quarters
CAT icon
84
Caterpillar
CAT
$368B
$375K 0.07%
+654
New +$363K
2025 Q4
0 quarters
GS icon
85
Goldman Sachs
GS
$261B
$372K 0.07%
+423
New +$345K
2025 Q4
0 quarters
MRK icon
86
Merck
MRK
$359B
$365K 0.07%
+3,468
New +$326K
2025 Q4
0 quarters
HI
87
PUT
DELISTED
Hillenbrand
HI
$358K 0.06%
+11,300
New +$348K
2025 Q4
0 quarters
PM icon
88
Philip Morris
PM
$314B
$349K 0.06%
+2,173
New +$337K
2025 Q4
0 quarters
RTX icon
89
RTX Corp
RTX
$251B
$344K 0.06%
+1,876
New +$326K
2025 Q4
0 quarters
ORCL icon
90
Oracle
ORCL
$429B
$342K 0.06%
+1,753
New +$417K
2025 Q4
0 quarters
GSK icon
91
GSK
GSK
$93.2B
$332K 0.06%
+6,770
New +$316K
2025 Q4
0 quarters
BA icon
92
Boeing
BA
$150B
$322K 0.06%
+1,481
New +$305K
2025 Q4
0 quarters
TMO icon
93
Thermo Fisher Scientific
TMO
$243B
$305K 0.05%
+526
New +$297K
2025 Q4
0 quarters
LRCX icon
94
Lam Research
LRCX
$399B
$305K 0.05%
+1,973
New +$307K
2025 Q4
0 quarters
MCD icon
95
McDonald's
MCD
$166B
$304K 0.05%
+995
New +$305K
2025 Q4
0 quarters
BCS icon
96
Barclays
BCS
$76.6B
$304K 0.05%
+11,937
New +$264K
2025 Q4
0 quarters
MS icon
97
Morgan Stanley
MS
$298B
$301K 0.05%
+1,698
New +$283K
2025 Q4
0 quarters
ABT icon
98
Abbott
ABT
$172B
$300K 0.05%
+2,398
New +$305K
2025 Q4
0 quarters
C icon
99
Citigroup
C
$217B
$294K 0.05%
+2,523
New +$262K
2025 Q4
0 quarters
AMAT icon
100
Applied Materials
AMAT
$402B
$289K 0.05%
+1,124
New +$269K
2025 Q4
0 quarters

Similar funds

DV Equities's Q4 2025 Portfolio in Review

Q4 2025 is the first quarter with a 13F filing on record for DV Equities, which disclosed 742 positions worth $558M. Its ten largest holdings account for 63% of the portfolio.

Its largest position is Vanguard FTSE Developed Markets ETF: 3,385,845 shares worth $212M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, followed by Technology and Healthcare.

  • DV Equities's largest Q4 2025 buy was Vanguard FTSE Developed Markets ETF: 3,385,845 shares worth $212M.
  • DV Equities's ten largest holdings make up 63% of its $558M portfolio in Q4 2025.
  • DV Equities disclosed 742 positions in Q4 2025, its first 13F filing on record.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.